An abundance of Escherichia coli is harbored by the mucosa-associated bacterial flora of interleukin-2-deficient mice.

PubWeight™: 0.92‹?›

🔗 View Article (PMC 375167)

Published in Infect Immun on April 01, 2004

Authors

M Schuppler1, K Lötzsch, M Waidmann, I B Autenrieth

Author Affiliations

1: Department of Medical Microbiology and Hygiene, Technical University Dresden, Dresden, Germany. Markus.Schuppler@ilw.agrl.ethz.ch

Articles citing this

Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4. PLoS One (2007) 2.05

Adherent and invasive Escherichia coli is associated with granulomatous colitis in boxer dogs. Infect Immun (2006) 1.26

The role of mucosal immunity and host genetics in defining intestinal commensal bacteria. Curr Opin Gastroenterol (2010) 1.15

Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models. Mutat Res (2010) 1.06

The mitochondrial and kidney disease phenotypes of kd/kd mice under germfree conditions. J Autoimmun (2005) 1.01

Sialic acid catabolism drives intestinal inflammation and microbial dysbiosis in mice. Nat Commun (2015) 0.88

Inhibitory effects of fermented brown rice on induction of acute colitis by dextran sulfate sodium in rats. Dig Dis Sci (2008) 0.86

Inflammatory bowel disease in rats: bacterial and chemical interaction. World J Gastroenterol (2008) 0.81

Dextran sodium sulfate-induced inflammation alters the expression of proteins by intestinal Escherichia coli strains in a gnotobiotic mouse model. Appl Environ Microbiol (2011) 0.79

Carrageenan Gum and Adherent Invasive Escherichia coli in a Piglet Model of Inflammatory Bowel Disease: Impact on Intestinal Mucosa-associated Microbiota. Front Microbiol (2016) 0.75

Microbial abundance on the eggs of a passerine bird and related fitness consequences between urban and rural habitats. PLoS One (2017) 0.75

Articles cited by this

Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbiol Rev (1995) 62.96

Fluorescent-oligonucleotide probing of whole cells for determinative, phylogenetic, and environmental studies in microbiology. J Bacteriol (1990) 28.74

Determination of microbial diversity in environmental samples: pitfalls of PCR-based rRNA analysis. FEMS Microbiol Rev (1997) 21.46

Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol (1999) 16.09

Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell (1993) 11.95

Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga-flavobacter-bacteroides in the natural environment. Microbiology (1996) 8.59

Design and evaluation of useful bacterium-specific PCR primers that amplify genes coding for bacterial 16S rRNA. Appl Environ Microbiol (1998) 8.58

Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol (1998) 8.56

Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun (1998) 7.86

Molecular microbial diversity of an anaerobic digestor as determined by small-subunit rDNA sequence analysis. Appl Environ Microbiol (1997) 6.04

Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology (1998) 5.02

Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J Clin Invest (1996) 4.59

The indigenous gastrointestinal microflora. Trends Microbiol (1996) 4.51

Phylogeny of the defined murine microbiota: altered Schaedler flora. Appl Environ Microbiol (1999) 3.76

Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect Immun (1999) 2.92

Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol (1999) 2.92

T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. Am J Pathol (1997) 2.76

Analysis of 16S libraries of mouse gastrointestinal microflora reveals a large new group of mouse intestinal bacteria. Microbiology (2002) 2.71

Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. Gastroenterology (1995) 2.47

Spatial distribution of Escherichia coli in the mouse large intestine inferred from rRNA in situ hybridization. Infect Immun (1994) 2.40

Molecular characterization of nocardioform actinomycetes in activated sludge by 16S rRNA analysis. Microbiology (1995) 2.15

Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am (1995) 2.14

Molecular analysis of the microbial diversity present in the colonic wall, colonic lumen, and cecal lumen of a pig. Appl Environ Microbiol (1999) 2.04

Ileal symbiont intracellularis, an obligate intracellular bacterium of porcine intestines showing a relationship to Desulfovibrio species. Int J Syst Bacteriol (1993) 2.01

Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli. Infect Immun (1999) 1.85

Escherichia coli antibodies in patients with inflammatory bowel disease. Gut (1978) 1.73

Molecular ecological analysis of the succession and diversity of sulfate-reducing bacteria in the mouse gastrointestinal tract. Appl Environ Microbiol (2000) 1.71

The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis. Gut (2000) 1.65

Intracellular Campylobacter-like organism from ferrets and hamsters with proliferative bowel disease is a Desulfovibrio sp. J Clin Microbiol (1994) 1.58

Development and proliferation of lymphocytes in mice deficient for both interleukins-2 and -4. Eur J Immunol (1994) 1.57

Bacteroides vulgatus protects against Escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice. Gastroenterology (2003) 1.53

Colonic bacteria express an ulcerative colitis pANCA-related protein epitope. Infect Immun (2000) 1.49

Incrimination of anaerobic bacteria in the induction of experimental colitis. Am J Physiol (1997) 1.20

Frequency of pathogenic and enteroadherent Escherichia coli in patients with inflammatory bowel disease and controls. J Clin Pathol (1997) 1.07

Correlation of cecal microflora of HLA-B27 transgenic rats with inflammatory bowel disease. Infect Immun (1998) 1.05

Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation. Gut (1997) 0.98

Expression of binding of plasminogen, thrombospondin, vitronectin, and fibrinogen, and adhesive properties by Escherichia coli strains isolated from patients with colonic diseases. Gut (1995) 0.93

In situ identification of nocardioform actinomycetes in activated sludge using fluorescent rRNA-targeted oligonucleotide probes. Microbiology (1998) 0.88

Absence of Escherichia coli, Listeria monocytogenes, and Klebsiella pneumoniae antigens within inflammatory bowel disease tissues. J Clin Pathol (1998) 0.85

Coliforms and enterococci isolated from the intestinal tract of conventional mice. Microb Ecol (1979) 0.76

Articles by these authors

Fluorescent In situ hybridization allows rapid identification of microorganisms in blood cultures. J Clin Microbiol (2000) 3.73

Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis. Lancet (2000) 2.04

IL-18 (IFN-gamma-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. J Immunol (1998) 1.73

Abiotrophia elegans sp. nov., a possible pathogen in patients with culture-negative endocarditis. J Clin Microbiol (1998) 1.68

Experimental Yersinia enterocolitica infection in rodents: a model for human yersiniosis. APMIS (1993) 1.60

Pneumocystis carinii carriage in immunocompetent patients with primary pulmonary disorders as detected by single or nested PCR. J Clin Microbiol (1999) 1.58

Early gamma interferon mRNA expression is associated with resistance of mice against Yersinia enterocolitica. Infect Immun (1994) 1.53

IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells. J Immunol (1996) 1.50

Evidence of a leading role for VEGF in Bartonella henselae-induced endothelial cell proliferations. Cell Microbiol (2001) 1.48

Comparison of MB/BacT and BACTEC 460 TB systems for recovery of mycobacteria in a routine diagnostic laboratory. J Clin Microbiol (1999) 1.43

Comparison of fluorescent in situ hybridization and conventional culturing for detection of Helicobacter pylori in gastric biopsy specimens. J Clin Microbiol (2001) 1.37

Innate defenses of the intestinal epithelial barrier. Cell Mol Life Sci (2005) 1.35

Interaction of Bartonella henselae with endothelial cells results in rapid bacterial rRNA synthesis and replication. Cell Microbiol (2000) 1.19

Role of plasmid-encoded antigens of Yersinia enterocolitica in humoral immunity against secondary Y. enterocolitica infection in mice. Microb Pathog (1993) 1.19

Gordonia polyisoprenivorans septicemia in a bone marrow transplant patient. Eur J Clin Microbiol Infect Dis (2004) 1.18

Interleukin-2 is indispensable for development of immunological self-tolerance. Clin Immunol Immunopathol (1996) 1.16

C-terminal amino acid residues of the trimeric autotransporter adhesin YadA of Yersinia enterocolitica are decisive for its recognition and assembly by BamA. Mol Microbiol (2010) 1.16

The gene slyA of Salmonella typhimurium is required for destruction of M cells and intracellular survival but not for invasion or colonization of the murine small intestine. Infect Immun (1996) 1.14

Culture independent and rapid identification of bacterial pathogens in necrotising fasciitis and streptococcal toxic shock syndrome by fluorescence in situ hybridisation. Med Microbiol Immunol (2000) 1.14

Protective role for heat shock protein-reactive alpha beta T cells in murine yersiniosis. Infect Immun (1994) 1.13

Cell surface presentation of recombinant (poly-) peptides including functional T-cell epitopes by the AIDA autotransporter system. FEMS Immunol Med Microbiol (2000) 1.12

Interaction of polymorphonuclear leukocytes with Yersinia enterocolitica: role of the Yersinia virulence plasmid and modulation by the iron-chelator desferrioxamine B. J Infect Dis (1994) 1.10

Wortmannin blocks Yersinia invasin-triggered internalization, but not interleukin-8 production by epithelial cells. Med Microbiol Immunol (1998) 1.09

Chronic prosthetic hip infection caused by a small-colony variant of Escherichia coli. J Clin Microbiol (1998) 1.08

Gene expression patterns of epithelial cells modulated by pathogenicity factors of Yersinia enterocolitica. Cell Microbiol (2004) 1.03

Yersinia enterocolitica invasin protein triggers differential production of interleukin-1, interleukin-8, monocyte chemoattractant protein 1, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor alpha in epithelial cells: implications for understanding the early cytokine network in Yersinia infections. Infect Immun (2000) 1.02

Ambiguous role of interleukin-12 in Yersinia enterocolitica infection in susceptible and resistant mouse strains. Infect Immun (1998) 1.01

Postinfectious irritable bowel syndrome: follow-up of a patient cohort of confirmed cases of bacterial infection with Salmonella or Campylobacter. Neurogastroenterol Motil (2011) 1.00

Microflora reactive IL-10 producing regulatory T cells are present in the colon of IL-2 deficient mice but lack efficacious inhibition of IFN-gamma and TNF-alpha production. Gut (2002) 0.99

Translocation of Yersinia entrocolitica across reconstituted intestinal epithelial monolayers is triggered by Yersinia invasin binding to beta1 integrins apically expressed on M-like cells. Cell Microbiol (2000) 0.97

Yersinia enterocolitica invasin protein triggers IL-8 production in epithelial cells via activation of Rel p65-p65 homodimers. FASEB J (2000) 0.96

Haemorrhagic fever with renal syndrome in Germany. Lancet (1991) 0.94

Interferon consensus sequence binding protein confers resistance against Yersinia enterocolitica. Infect Immun (2000) 0.93

Yersinia-hsp60-reactive T cells are efficiently stimulated by peptides of 12 and 13 amino acid residues in a MHC class II (I-Ab)-restricted manner. Clin Exp Immunol (1996) 0.92

Trimer stability of YadA is critical for virulence of Yersinia enterocolitica. Infect Immun (2010) 0.92

Clonal spread of meropenem-resistant Acinetobacter baumannii strains in hospitals in the Mediterranean region and transmission to South-west Germany. J Hosp Infect (2005) 0.91

Discrimination between epidemic and non-epidemic glycopeptide-resistant E. faecium in a post-outbreak situation. J Hosp Infect (2007) 0.91

Emergence of increasing linezolid-resistance in enterococci in a post-outbreak situation with vancomycin-resistant Enterococcus faecium. Epidemiol Infect (2007) 0.91

Yersinia enterocolitica-induced interleukin-8 secretion by human intestinal epithelial cells depends on cell differentiation. Infect Immun (1998) 0.91

Evaluation of the ICT malaria Pf test for rapid post-mortem diagnosis of Plasmodium falciparum malaria in corpses examined for forensic reasons. Int J Legal Med (2000) 0.90

Bartholinitis due to Streptococcus pneumoniae: case report and review. Clin Infect Dis (1998) 0.90

The Yersinia enterocolitica invasin protein promotes major histocompatibility complex class I- and class II-restricted T-cell responses. Infect Immun (2006) 0.90

Interaction of Listeria monocytogenes with the intestinal epithelium. FEMS Microbiol Lett (2000) 0.88

DNA immunization confers systemic, but not mucosal, protection against enteroinvasive bacteria. Eur J Immunol (1999) 0.86

Interleukin-12 and interleukin-18 are indispensable for protective immunity against enteropathogenic Yersinia. Microb Pathog (2001) 0.85

Pulmonary toxoplasmosis in bone marrow transplant recipients: report of two cases and review. Clin Infect Dis (1999) 0.84

Rapid identification of pathogens in blood. Ann Intern Med (2000) 0.84

Cat scratch disease due to Bartonella henselae infection mimicking parotid malignancy. Eur J Clin Microbiol Infect Dis (2001) 0.83

Efficacy and potential clinical applications of Pentaglobin, an IgM-enriched immunoglobulin concentrate suitable for intravenous infusion. Eur J Surg Suppl (1999) 0.82

Seroprevalence of Bartonella henselae in cats in Germany. J Med Microbiol (1999) 0.81

In vivo tracking and protective properties of Yersinia-specific intestinal T cells. Clin Exp Immunol (1998) 0.81

Rational live oral carrier vaccine design by mutating virulence-associated genes of Yersinia enterocolitica. Infect Immun (1999) 0.81

Microbial heat shock proteins as vaccine. Behring Inst Mitt (1997) 0.80

Life-threatening pneumonia caused by human cytomegalovirus and Mycoplasma pneumoniae coinfection in a young, immunocompetent patient. J Med Microbiol (2010) 0.79

[Endemic occurrence of hemorrhagic fever with renal syndrome in the Federal Republic of Germany]. Z Arztl Fortbild (Jena) (1991) 0.78

Soft-tissue abscess caused by Salmonella enterica serovar Enteritidis at the site of melanoma metastasis. Clin Microbiol Infect (2004) 0.77

Conjugation of hydroxyethyl starch to desferrioxamine (DFO) modulates the dual role of DFO in Yersinia enterocolitica infection. Clin Diagn Lab Immunol (2000) 0.77

A closed system for islet isolation and purification using the COBE2991 cell processor may reduce the need of clean room facilities. Cell Transplant (2007) 0.76

DNA vaccination using coexpression of cytokine genes with a bacterial gene encoding a 60-kDa heat shock protein. Med Microbiol Immunol (2000) 0.75

Metallo-beta-lactamase expressing multi-resistant Acinetobacter baumannii transmitted in the operation area. J Hosp Infect (2004) 0.75

Animal studies on the kinetics of benzidine and 3,3'-dichlorobenzidine. Arch Toxikol (1973) 0.75

International Forum on GMP-grade human platelet lysate for cell propagation: summary. Vox Sang (2017) 0.75